Wells Fargo’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,000
Closed -$14K 7905
2021
Q4
$14K Buy
+1,000
New +$13.4K ﹤0.01% 6443
2021
Q3
Sell
-120,000
Closed -$1.72M 7587
2021
Q2
$1.72M Sell
120,000
-134,700
-53% -$1.95M ﹤0.01% 3818
2021
Q1
$3.56M Buy
254,700
+221,100
+658% +$3.6M ﹤0.01% 3174
2020
Q4
$47K Buy
+33,600
New +$548K ﹤0.01% 5603
2017
Q1
Sell
-160,000
Closed -$3K 6537
2016
Q4
$3K Hold
160,000
﹤0.01% 6052
2016
Q3
$43K Hold
160,000
﹤0.01% 5362
2016
Q2
$394K Hold
160,000
﹤0.01% 4045
2016
Q1
$760K Sell
160,000
-66,600
-29% -$3.21M ﹤0.01% 3581
2015
Q4
$1.68M Hold
226,600
﹤0.01% 3108
2015
Q3
$684K Buy
226,600
+185,000
+445% +$10.3M ﹤0.01% 3747
2015
Q2
$10K Buy
+41,600
New +$2.94M ﹤0.01% 5817
2014
Q4
Sell
-250,000
Closed -$19K 6436
2014
Q3
$19K Hold
250,000
﹤0.01% 5338
2014
Q2
$838K Buy
+250,000
New +$12.3M ﹤0.01% 3635

Other funds holding VTRS

Wells Fargo's VTRS Position: Q1 2026 in Review

Wells Fargo reduced its Viatris (VTRS) stake by 4.9% in Q1 2026, selling an estimated $837K and leaving 1,160,097 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Wells Fargo first reported a position in VTRS in Q2 2013 and has held it in 52 quarters since. The position peaked at $166M in Q2 2015. 1,020 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Wells Fargo held 1,160,097 shares of Viatris worth $15.7M as of Q1 2026.
  • Wells Fargo sold 59,820 Viatris shares in Q1 2026, an estimated $837K.
  • Viatris made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1685 holding.
  • Wells Fargo first reported a position in Viatris in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Viatris position peaked at $166M in Q2 2015.
  • 1,020 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.